SG11201401226YA - Guanidinyl-substituted polyamides useful for treating human papilloma virus - Google Patents

Guanidinyl-substituted polyamides useful for treating human papilloma virus

Info

Publication number
SG11201401226YA
SG11201401226YA SG11201401226YA SG11201401226YA SG11201401226YA SG 11201401226Y A SG11201401226Y A SG 11201401226YA SG 11201401226Y A SG11201401226Y A SG 11201401226YA SG 11201401226Y A SG11201401226Y A SG 11201401226YA SG 11201401226Y A SG11201401226Y A SG 11201401226YA
Authority
SG
Singapore
Prior art keywords
guanidinyl
papilloma virus
human papilloma
treating human
polyamides useful
Prior art date
Application number
SG11201401226YA
Inventor
James K Bashkin
Terri G Edwards
Christopher Fisher
Jr George D Harris
Kevin J Koeller
Original Assignee
Nanovir Llc
Univ Missouri
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanovir Llc, Univ Missouri filed Critical Nanovir Llc
Publication of SG11201401226YA publication Critical patent/SG11201401226YA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • C07K14/003Peptide-nucleic acids (PNAs)
SG11201401226YA 2011-10-10 2012-10-10 Guanidinyl-substituted polyamides useful for treating human papilloma virus SG11201401226YA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161545311P 2011-10-10 2011-10-10
PCT/US2012/059604 WO2013055825A2 (en) 2011-10-10 2012-10-10 Guanidinyl-substituted polyamides useful for treating human papilloma virus

Publications (1)

Publication Number Publication Date
SG11201401226YA true SG11201401226YA (en) 2014-05-29

Family

ID=48042465

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201401226YA SG11201401226YA (en) 2011-10-10 2012-10-10 Guanidinyl-substituted polyamides useful for treating human papilloma virus

Country Status (12)

Country Link
US (1) US9133228B2 (en)
EP (1) EP2751096A4 (en)
JP (1) JP2015502330A (en)
KR (1) KR20140074996A (en)
CN (1) CN104024247B (en)
AU (1) AU2012322835A1 (en)
BR (1) BR112014008464A2 (en)
CA (1) CA2851516C (en)
HK (1) HK1201064A1 (en)
RU (1) RU2014113702A (en)
SG (1) SG11201401226YA (en)
WO (1) WO2013055825A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9982020B2 (en) * 2011-10-10 2018-05-29 Nanovir Llc Antiviral compounds and methods for treating infections caused by double-stranded DNA viruses
WO2016022664A1 (en) 2014-08-05 2016-02-11 Nanovir Llc Antiviral compounds and methods for treating infections caused by double-stranded dna viruses

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7380294A (en) 1993-08-06 1995-02-28 Synphar Laboratories, Inc. Oligopeptide antiretroviral agents
CN1260006A (en) 1996-02-26 2000-07-12 加利福尼亚州技术学院 Complex formation between dsDNA and oligomer of heterocycles
WO1998037066A1 (en) 1996-02-26 1998-08-27 California Institute Of Technology Improved polyamides for binding in the minor groove of double stranded dna
AU6255298A (en) 1996-02-26 1998-09-09 California Institute Of Technology Design, synthesis and use of specific polyamide dna-binding ligands
US5998140A (en) 1996-07-31 1999-12-07 The Scripps Research Institute Complex formation between dsDNA and oligomer of cyclic heterocycles
WO1998035702A1 (en) 1996-08-01 1998-08-20 California Institute Of Technology Inhibition of gene transcription by polyamide dna-binding ligands
WO2000015773A2 (en) 1998-09-11 2000-03-23 California Institute Of Technology Inhibition of oncogene transcription by synthetic polyamides
US6673940B1 (en) 1999-01-08 2004-01-06 California Institute Of Technology Compositions and methods relating to cyclic compounds that undergo nucleotide base pair-specific interactions with double-stranded nucleic acids
JP4012145B2 (en) 2001-06-25 2007-11-21 独立行政法人科学技術振興機構 Solid phase synthesis of pyrrole-imidazole polyamide
MXPA04004361A (en) 2001-11-07 2005-03-31 Pharmacia Corp Methods of promoting uptake and nuclear accumulation of polyamides in eukaryotic cells.
WO2003040337A2 (en) 2001-11-07 2003-05-15 Pharmacia Corporation Polyamide modulators of cox2 transcription
ATE468147T1 (en) 2003-01-16 2010-06-15 Femmepharma Holding Co Inc VAGINAL OR RECTAL APPLICATOR AND METHOD
WO2004078943A2 (en) 2003-03-04 2004-09-16 California Institute Of Technology Alternative heterocycles for dna recognition
US20050009054A1 (en) 2003-04-30 2005-01-13 Pharmacia Corporation Compounds having a fused, bicyclic moiety for binding to the minor groove of dsDNA
US8399013B2 (en) 2003-06-26 2013-03-19 Poly-Med, Inc. Partially absorbable fiber-reinforced composites for controlled drug delivery
WO2005033282A2 (en) * 2003-10-01 2005-04-14 Pharmacia & Upjohn Company Llc Polyamide compositions and therapeutic methods for treatment of human papilloma virus
DE10357677A1 (en) 2003-12-10 2005-07-14 Greiner Bio-One Gmbh Primers and probes for detecting genital HPV genotypes
WO2007045096A1 (en) * 2005-10-21 2007-04-26 University Of Saskatchewan Oligoheteroaromatic luminiscent assemblies as high-affinity dna sequence-directed ligands
WO2007103584A2 (en) * 2006-03-09 2007-09-13 Nanovir, Llc Polyamides for treating human papilloma virus
JP5371743B2 (en) * 2006-05-04 2013-12-18 ナノビール・リミテッド・ライアビリティ・カンパニー Polyamides for treating human papillomavirus
US8993609B2 (en) 2006-05-04 2015-03-31 Nanovir, Llc Compounds for treating papilloma virus infection

Also Published As

Publication number Publication date
CA2851516C (en) 2016-08-02
CN104024247B (en) 2016-05-25
CN104024247A (en) 2014-09-03
US9133228B2 (en) 2015-09-15
RU2014113702A (en) 2015-11-20
US20130090362A1 (en) 2013-04-11
JP2015502330A (en) 2015-01-22
WO2013055825A2 (en) 2013-04-18
BR112014008464A2 (en) 2017-04-11
WO2013055825A3 (en) 2013-06-13
HK1201064A1 (en) 2015-08-21
CA2851516A1 (en) 2013-04-18
AU2012322835A1 (en) 2014-04-17
NZ623292A (en) 2016-02-26
KR20140074996A (en) 2014-06-18
EP2751096A4 (en) 2015-04-08
EP2751096A2 (en) 2014-07-09

Similar Documents

Publication Publication Date Title
SG10201602013SA (en) Treatment for peanut allergy
GB201119111D0 (en) Illumination apparatus
EP2755612A4 (en) Ankle walker
HK1199649A1 (en) Process for the preparation of polyamides
EP2780631A4 (en) Connectable lighting apparatus
EP2664845A4 (en) Illumination apparatus
GB2491411B (en) Exhaust after treatment device mode regulation
HK1201064A1 (en) Guanidinyl-substituted polyamides useful for treating human papilloma virus
ZA201404542B (en) Fabric treatment composition
ZA201308117B (en) Avian-based treatment
GB201105523D0 (en) Treatment method
GB2489207B (en) Waste treatment
GB201111247D0 (en) Treatment
GB201109119D0 (en) Treatment
GB201102267D0 (en) Treatment
GB201102269D0 (en) Treatment
GB201102263D0 (en) Treatment
GB201102275D0 (en) Treatment
GB201102271D0 (en) Treatment
GB201102288D0 (en) Treatment
GB201102284D0 (en) Treatment
GB201102282D0 (en) Treatment
GB201102277D0 (en) Treatment
GB201102276D0 (en) Treatment
GB201102265D0 (en) Treatment